NM_016373.4:c.1057-261369C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016373.4(WWOX):​c.1057-261369C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.612 in 151,978 control chromosomes in the GnomAD database, including 28,904 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.61 ( 28904 hom., cov: 32)

Consequence

WWOX
NM_016373.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.378

Publications

6 publications found
Variant links:
Genes affected
WWOX (HGNC:12799): (WW domain containing oxidoreductase) This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) protein family. This gene spans the FRA16D common chromosomal fragile site and appears to function as a tumor suppressor gene. Expression of the encoded protein is able to induce apoptosis, while defects in this gene are associated with multiple types of cancer. Disruption of this gene is also associated with autosomal recessive spinocerebellar ataxia 12. Disruption of a similar gene in mouse results in impaired steroidogenesis, additionally suggesting a metabolic function for the protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
WWOX Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive spinocerebellar ataxia 12
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • developmental and epileptic encephalopathy, 28
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • 46,XY partial gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.68 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016373.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WWOX
NM_016373.4
MANE Select
c.1057-261369C>T
intron
N/ANP_057457.1
WWOX
NM_001291997.2
c.718-261369C>T
intron
N/ANP_001278926.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WWOX
ENST00000566780.6
TSL:1 MANE Select
c.1057-261369C>T
intron
N/AENSP00000457230.1
WWOX
ENST00000402655.6
TSL:1
c.410-261369C>T
intron
N/AENSP00000384238.2
WWOX
ENST00000406884.6
TSL:1
c.517-261369C>T
intron
N/AENSP00000384495.2

Frequencies

GnomAD3 genomes
AF:
0.612
AC:
92898
AN:
151858
Hom.:
28876
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.687
Gnomad AMI
AF:
0.646
Gnomad AMR
AF:
0.602
Gnomad ASJ
AF:
0.730
Gnomad EAS
AF:
0.541
Gnomad SAS
AF:
0.606
Gnomad FIN
AF:
0.473
Gnomad MID
AF:
0.734
Gnomad NFE
AF:
0.588
Gnomad OTH
AF:
0.637
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.612
AC:
92977
AN:
151978
Hom.:
28904
Cov.:
32
AF XY:
0.605
AC XY:
44970
AN XY:
74284
show subpopulations
African (AFR)
AF:
0.686
AC:
28457
AN:
41462
American (AMR)
AF:
0.602
AC:
9192
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.730
AC:
2536
AN:
3472
East Asian (EAS)
AF:
0.541
AC:
2793
AN:
5158
South Asian (SAS)
AF:
0.606
AC:
2919
AN:
4818
European-Finnish (FIN)
AF:
0.473
AC:
4988
AN:
10544
Middle Eastern (MID)
AF:
0.735
AC:
216
AN:
294
European-Non Finnish (NFE)
AF:
0.588
AC:
39939
AN:
67948
Other (OTH)
AF:
0.639
AC:
1348
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1826
3651
5477
7302
9128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.605
Hom.:
87779
Bravo
AF:
0.627
Asia WGS
AF:
0.613
AC:
2134
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
5.5
DANN
Benign
0.82
PhyloP100
0.38
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1995549; hg19: chr16-78984136; API